Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Instruments’ HCR™ platform enables multiplexed, quantitative bioimaging of RNA and proteins in intact tissues. Their HCR™ Gold product line allows simultaneous 10-target detection with enzyme-free signal amplification for both RNA-FISH and immunofluorescence. The HCR™ Pro line offers enzymatic amplification for extreme sensitivity. Their technology has been implemented in clinical settings for laboratory-developed tests (LDTs), notably advancing precision medicine applications such as tissue-based biomarker analysis in dermatological diseases like psoriasis and eczema[1][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Instruments.